Summary & Overview
HCPCS J7642: Glycopyrrolate Inhalation Solution, Concentrated, per mg
HCPCS Level II code J7642 designates a compounded glycopyrrolate inhalation solution supplied in concentrated form and administered via durable medical equipment (DME), billed per milligram. This code matters nationally as inhaled anticholinergic therapies like glycopyrrolate are increasingly used for management of respiratory conditions requiring device-based delivery, and compounded formulations can introduce distinct billing and procurement considerations.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for inhaled glycopyrrolate delivered through DME, common sites of service, and the payer mix typically relevant to reimbursement discussions. The publication summarizes benchmark considerations, coding context for compounded inhalation products, and practical information for billing teams.
This analysis does not provide state-specific rules; it addresses national coding and clinical implications. Data not available in the input are noted where applicable, including detailed payer-specific coverage policies, associated taxonomies, ICD-10 diagnoses, and related billing codes. The content aims to equip coding, revenue cycle, and clinical operations teams with a clear understanding of what HCPCS Level II code J7642 represents and where it fits in inhalation therapy billing workflows.
Billing Code Overview
HCPCS Level II code J7642 describes glycopyrrolate, inhalation solution, compounded product, administered through DME, concentrated form, per milligram. This code represents a compounded inhalation medication formulation of glycopyrrolate provided for administration via durable medical equipment, typically as a concentrated solution requiring dilution or preparation before delivery to a patient.
Service type: Drug administration through durable medical equipment (inhalation therapy).
Typical site of service: Home or outpatient setting where durable medical equipment (DME) is used.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed payment information.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with chronic obstructive pulmonary disease (COPD) or chronic bronchitis experiencing persistent bronchospasm and excessive secretions despite optimised inhaled bronchodilator therapy. The patient receives a compounded inhalation solution of glycopyrrolate (J7642) prepared and dispensed by a licensed pharmacy, delivered to the patient’s home and administered through a durable medical equipment (DME) nebulizer or inhalation device. Clinical workflow: outpatient pulmonology or primary care documents the medical necessity and prescribes the compounded concentrated glycopyrrolate solution with dose in milligrams; the prescription is transmitted to the compounding pharmacy; the pharmacy compounds the inhalation solution, packages it for DME administration, and bills using J7642 per milligram; the DME provider furnishes the nebulizer and supplies, provides device training, and documents patient tolerance and adherence during home visits or telehealth follow-up. Typical site of service is outpatient clinic, pharmacy-compounded supply delivered to home, or home health setting when DME is used for administration.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier from this list applies to the billed service. |